GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (OTCPK:NNCSF) » Definitions » Accounts Payable & Accrued Expense

Nanosonics (Nanosonics) Accounts Payable & Accrued Expense : $6.0 Mil (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Nanosonics Accounts Payable & Accrued Expense?

Nanosonics's quarterly accounts payable & accrued expense increased from Dec. 2022 ($6.9 Mil) to Jun. 2023 ($7.3 Mil) but then declined from Jun. 2023 ($7.3 Mil) to Dec. 2023 ($6.0 Mil).

Nanosonics's annual accounts payable & accrued expense increased from Jun. 2021 ($5.5 Mil) to Jun. 2022 ($6.7 Mil) and increased from Jun. 2022 ($6.7 Mil) to Jun. 2023 ($7.3 Mil).

Nanosonics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Nanosonics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosonics Accounts Payable & Accrued Expense Chart

Nanosonics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.86 5.30 5.50 6.73 7.28

Nanosonics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.45 6.73 6.92 7.28 6.02

Nanosonics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Nanosonics (Nanosonics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (OTCPK:NNCSF) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
ASX:TRJ ASX:SDI ASX:AHC ASX:OSX ASX:ANN ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD OCSE:COLO B TSE:4543 WST XSWX:STMN XPAR:DIM TSE:7733 COO BAX HOLX
Traded in Other Exchanges
OQS:Germany NAN:Australia
Address
7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113
Website
https://www.nanosonics.com.au
Nanosonics is a single-product firm and its trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low temperature sonically activated hydrogen peroxide mist that is suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection across patients. Nanosonics' revenue is made up of capital sales of trophon units, ongoing consumables sales, and service revenue. At June 2022, there were 29,850 trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, roughly 44% in the U.S. to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in Asia-Pacific.